Trivarx Ltd has released a press release.
Quarterly Activities Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- Receipt of $3,074,224 R & D Tax Incentive Refund
- Partners with HBF and Vital Conversations on mental health
- Funding Update
- Medibio and Monash Groundbreaking partnership on innovation
- Commercial Trial and Validation Update
Later from TrivarX
- Outstanding 86% accuracy in 889 person Ottawa Uni study
- ANZ: Opes Prime Disclosure
- Capital raising of $13.5million to accelerate growth
- Medibio enters into binding agreement with Medtronic
- Excellent performance in the pilot phase of US Validation
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX